Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Applying valproic acid on the scalp increased hair growth in men with hair loss.

An arthritis drug helped a person with severe hair loss regrow their hair.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Cannabidivarin (CBDV) helps new brain cells grow and develop in a specific brain area through a certain receptor.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.